2026-01-21 - Analysis Report
**Company Overview**
Northrop Grumman is a global aerospace and defense technology company.

**Return Rate Analysis**
* Return Rate (Rate): 57.79%
* Return Rate of S&P 500 (VOO) (Rate_VS): 89.37%
* Divergence (Difference in Cumulative Return): -31.58%

The divergence of -31.58% indicates that the stock's return rate is 31.58% lower than the S&P 500's return rate.

**Alpha and Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -6.0% | 23.7% | -11.0% | 0.7  | 35.1B |
| 2017-2019  | 15.0% | 23.7% | -2.0%  | 0.7  | 49.2B |
| 2018-2020  | -25.0% | 23.7% | -46.0% | 0.8  | 43.6B |
| 2019-2021  | 40.0% | 12.9% | -3.0%  | 0.7  | 55.4B |
| 2020-2022  | 18.0% | 16.9% | 19.0%  | 0.6  | 78.1B |
| 2021-2023  | 23.0% | 16.9% | 22.0%  | 0.3  | 67.0B |
| 2022-2024  | -14.0% | 16.9% | -33.0% | 0.3  | 67.2B |
| 2023-2025  | -1.0%  | 17.7% | -63.0% | 0.1  | 81.6B |

**Recent Stock Price Fluctuations**

* Close: $657.30
* Last-Market Change: -$1.44 (-1.44%)
* 5-day SMA: $651.49
* 20-day SMA: $604.82
* 60-day SMA: $580.37

The stock price has shown a moderate decline, but the 5-day SMA is higher than the 20-day SMA, indicating a possible buy signal.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis**

* Market Risk Indicator (MRI): 0.80 (Medium Risk)
* RSI: 70.91 (Neutral)
* PPO: 1.15 (Bullish)
* Hybrid Signal: Buy (Cash 0%)
* Recent Relative Divergence Change: 11.40 (+) improving
* 7-day Rank Change: 36 (+) rank up
* 7-day Dynamic Expected Return Change: 6.40 (+) improving
* Expected Return: -39.90% (sharp rebound or decline)

The stock is considered to be in a neutral position, with both positive and negative signals. The expected return is -39.90%, indicating a potential for sharp rebound or decline.

**Recent News & Significant Events**

Please see the following news headlines:

- Northrop Grumman (NOC) Projected to Post Quarterly Earnings on Tuesday - (news.google.com)
- Whatâ€™s The Risk For Northrop Grumman Stock As Trump Curbs Dividends And Executive Pay? - (news.google.com)
- Stocks making the biggest moves premarket: Lockheed Martin, Northrop Grumman, Gap, Alcoa & more - (news.google.com)
- Northrop Grumman Stock Hits All-Time High, Gets Rating Upgrade - (news.google.com)
- Why Northrop Grumman (NOC) Stock Is Up Today - (news.google.com)
- Northrop Grumman: $1.5 Trillion Defense Budget Boosts F/A-XX Win (Rating Upgrade) - (news.google.com)

**Analyst Opinions**

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
  - Opinions: 21
  - Target Price (avg/high/low): 673.72 / 777.00 / 576.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-10-21 | 7.69 | $10.42B |
| 2025-07-22 | 8.17 | $10.35B |
| 2025-04-22 | 3.33 | $9.47B  |
| 2024-10-24 | 7.02 | $10.00B |
| 2025-10-21 | 7.02 | $10.00B |

The earnings growth is moderate, with two consecutive quarters of revenue growth.

**Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $10.42B | 21.37% |
| 2025-06-30 | $10.35B | 21.35% |
| 2025-03-31 | $9.47B  | 16.69% |
| 2024-12-31 | $10.69B | 18.08% |
| 2024-09-30 | $10.00B | 21.07% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $15.99B | 6.88% |
| 2025-06-30 | $15.47B | 7.59% |
| 2025-03-31 | $14.98B | 3.21% |
| 2024-12-31 | $15.29B | 8.27% |
| 2024-09-30 | $14.75B | 6.96% |

The company has shown consistent revenue growth, but the profit margin has been moderate. The equity has increased over the past year.

**Comprehensive Analysis**

The stock has shown a moderate decline in return rate compared to the S&P 500. The Alpha and Beta analysis indicates a moderate level of risk and uncertainty. The recent stock price fluctuations suggest a possible buy signal. The RSI, PPO, and Delta_Previous_Relative_Divergence analysis indicate a neutral position with both positive and negative signals. The expected return is -39.90%, indicating a potential for sharp rebound or decline. The recent news and significant events suggest a positive outlook for the company. The analyst opinions are generally positive, with a mean rating of 2.17 (buy) and a target price of $673.72. The recent earnings analysis suggests moderate earnings growth. The financial information indicates consistent revenue growth but moderate profit margin.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.